Recall Register

Food, drugs, devices › Fresenius Kabi USA, LLC

Device recall: Ivenix Infusion System (IIS), Large Volume Pump, Model Number: LVP-0004

FDA enforcement event 98945 · Class I · initiated 6 May 2026 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordNorth Andover, MA

Fresenius Kabi USA, LLC (North Andover, MA) initiated this device recall on 6 May 2026; FDA lists 1 product record under event 98945, classified Class I.

FDA defines Class I as a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. 12% of the 572 device enforcement events initiated in 2026 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Fresenius Kabi USA, LLC has 67 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Fresenius Kabi USA, LLC, North Andover, MA.

Reason for recall

"Fresenius Kabi has been made aware via customer complaints that dropping or severe jarring of the Ivenix LVP may cause damage to internal components that may not be apparent or readily visible and the devices therefore remained in service. More specifically, drops or jarring on a hard surface can cause the touchscreen input cable to loosen, resulting in unintended touchscreen behavior on the…"

Distribution

"Domestic: CA, CO, FL, GA, ID, IL, MD, MI, MI , MN, MO, MS, NE, NJ, NV, OK, OR, SC, TX, VA, WA, WI, WI;"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2224-2026Ivenix Infusion System (IIS), Large Volume Pump, Model Number: LVP-000418,444Class IOngoing10 Jun 2026

Context

12%of 2026 device events are Class I572 events that year
1product record in this eventfirm median: 1
67events on this register for the firm

Other enforcement events for Fresenius Kabi USA, LLC

InitiatedProduct (first record)TypeClassRecords
10 Aug 2026Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LDrugClass I1
4 Aug 2026Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or IntravenouDrugClass I1
16 Jul 2026Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose ViDrugClass II5
14 May 2026Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-696DrugClass III1
6 May 2026LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.DeviceClass I1
11 Mar 20260.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL freeflex bag, Rx only, DrugClass II14
4 Feb 2026The Large Volume Pump (LVP) of the Ivenix Infusion System (IIS). Model Number: LVP-0004.DeviceClass II1
21 Nov 2025Ivenix Infusion System (IIS), LVP Software: LVP-SW-0005.DeviceClass II1
14 Nov 2025Ivenix Infusion System (IIS), LVP Software LVP-SW-0005. Software for the controlled administration of fluids to patientsDeviceClass I1
6 Nov 2025Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11DrugClass I1

All 67 events for Fresenius Kabi USA, LLC

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Fresenius Kabi has been made aware via customer complaints that dropping or severe jarring of the Ivenix LVP may cause damage to internal components that may not be apparent or readily visible and the devices therefore remained in service. More specifically, drops or jarring on a hard surface can cause the touchscreen input cable to loosen, resulting in unintended touchscreen behavior on the…"

What does Class I mean?

FDA classifies recalls by relative degree of health hazard. Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

Where was the product distributed?

FDA's distribution pattern field reads: "Domestic: CA, CO, FL, GA, ID, IL, MD, MI, MI , MN, MO, MS, NE, NJ, NV, OK, OR, SC, TX, VA, WA, WI, WI;"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.